The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s drug device combination market report forecasts the drug device combination market size to grow to $179.10 Billion by 2027, with a CAGR (compound annual growth rate) of more than 10%.

Learn More On The Drug Device Combination Market Report 2023 – https://www.thebusinessresearchcompany.com/report/drug-device-combination-global-market-report

Drug Device Combination Market Size Forecast
The global drug device combination market is expected to grow from $108.43 billion in 2022 to $121.17 billion in 2023 at a compound annual growth rate (CAGR) of 11.75%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The drug-device combination market is expected to grow to $179.10 billion in 2027 at a CAGR of 10.26%.

North America held the largest drug device combination market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Drug Device Combination Market Driver ­– Increase In The Prevalence Of Chronic Diseases
For instance, according to a report by the World Health Organization, a specialized body of the United Nations to ensure international public health, in 2022, diabetes affected more than 420 million individuals globally. By 2030 and 2045, these numbers are expected to increase to 578 million and 700 million, respectively. Hence, the increasing prevalence of chronic diseases is driving the growth of the drug-device combination market.

Request for A Sample Of The Global Drug Device Combination Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8206&type=smp

Key Drug Device Combination Market Trend – Technological Advancement
New technologies are being introduced by major corporations in the market that works on self-adjusting plunger stopper detection technology to sustain their position in the market. For instance, in September 2021, Owen Mumford, a UK-based medical device manufacturing company, launched the Aidaptus auto-injector platform. Aidaptus is a two-stage, spring-powered, single-use auto-injector with a base unit that can hold both prefilled glass syringes measuring 1.25 ml and 2.25 ml. It is a hypodermic syringe that one can use to administer medication. It features self-adjusting plunger stopper sensing technology that automatically adjusts to the various stopper positions and fills levels in each syringe without needing additional parts.

Drug Device Combination Market Segment
1) By Product: Auto-Injector, Microneedle Patch, Digital Pill, Smart Inhaler, Drug Delivery Hydrogels, Drug-Eluting Lens, Other Products
2) By Application: Orthopedic Diseases, Respiratory Diseases, Diabetes, Oncology, Cardiovascular Diseases, Other Applications
3) By End User: Clinics, Hospitals, Home Care Settings, Ambulatory Care Centers, Other End Users
4) By Distribution Channel: Direct Tender, Retails Sales, Other Distribution Channels

Drug Device Combination Market Major Players and Strategies
Major players in the drug device combination market are The 3M Company, Abbott Laboratories, Biotronik, Boston Scientific Corporation, C.R. Bard Inc., Medtronic PLC., Amgen Inc., Ypsomed, Micron Biomedical Inc., MetP Pharma AG, Sonceboz, Propeller Health B.D., Lepu Medical Technology, Eitan Medical Ltd., Vaxess Technologies Inc., and Subcuject Aps.

In July 2021, BD, a US-based medical device company, acquired Zebrasci for an undisclosed amount. This acquisition will enable BD to expand its contract development service capabilities, including testing and validation of combination products to strengthen its position in the market. Zebrasci is a US-based biotechnology company that helps develop combination products.

The Drug Device Combination Global Market Report 2023 covers regional data on drug device combination market size, drug device combination market trends and drivers, opportunities, strategies, and drug device combination market competitor analysis. The countries covered in the drug device combination market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Drug-device combination refers to therapeutic and diagnostic products that associate a medical device with a drug for local administration of the drug, precise drug targeting, and individualized therapy. These are physically and chemically combined to produce a single entity and packaged together in a single package. The drug-device combination is used in clinical development to deliver drugs to the desired location in the body.

View More Reports Related To The Drug Device Combination Market –
Drugs For Erectile Dysfunction Global Market Report 2023
Drug Delivery Devices Global Market Report 2023
Drug Discovery Services Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: